Insider Transactions in Q1 2024 at Phreesia, Inc. (PHR)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 25
2024
|
Balaji Gandhi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,504
-3.59%
|
$80,592
$23.21 P/Share
|
|
Mar 21
2024
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
25,962
-1.72%
|
$597,126
$23.97 P/Share
|
|
Mar 20
2024
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Indirect |
30
-0.42%
|
$690
$23.66 P/Share
|
|
Mar 20
2024
|
Janet Gunzburg Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
137
-0.35%
|
$3,151
$23.66 P/Share
|
|
Mar 19
2024
|
Janet Gunzburg Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,817
-6.49%
|
$64,791
$23.27 P/Share
|
|
Mar 19
2024
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Indirect |
402
-5.34%
|
$9,246
$23.27 P/Share
|
|
Mar 18
2024
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Indirect |
46
-0.61%
|
$1,012
$22.22 P/Share
|
|
Feb 09
2024
|
Janet Gunzburg Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
480
-1.21%
|
$13,440
$28.0 P/Share
|
|
Feb 02
2024
|
Janet Gunzburg Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
480
-1.2%
|
$12,960
$27.0 P/Share
|
|
Feb 01
2024
|
Janet Gunzburg Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
328
-0.81%
|
$8,200
$25.99 P/Share
|
|
Jan 31
2024
|
Gillian Munson Director |
BUY
Grant, award, or other acquisition
|
Direct |
392
+1.44%
|
$9,800
$25.48 P/Share
|
|
Jan 31
2024
|
Edward L Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
392
+0.85%
|
$9,800
$25.48 P/Share
|
|
Jan 31
2024
|
Lainie Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
392
+1.24%
|
$9,800
$25.48 P/Share
|
|
Jan 17
2024
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
63,931
-4.99%
|
$1,534,344
$24.12 P/Share
|
|
Jan 17
2024
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
41,081
-5.16%
|
$985,944
$24.12 P/Share
|
|
Jan 17
2024
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
7,605
-5.26%
|
$182,520
$24.12 P/Share
|
|
Jan 17
2024
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
30,659
-13.06%
|
$735,816
$24.12 P/Share
|
|
Jan 17
2024
|
Michael J. Davidoff SVP, Payer Business |
SELL
Open market or private sale
|
Direct |
17,677
-19.41%
|
$424,248
$24.12 P/Share
|
|
Jan 17
2024
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
10,213
-7.86%
|
$245,112
$24.12 P/Share
|
|
Jan 17
2024
|
Balaji Gandhi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,192
-8.61%
|
$220,608
$24.12 P/Share
|
|
Jan 16
2024
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,586
-0.28%
|
$86,064
$24.55 P/Share
|
|
Jan 16
2024
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,247
-0.28%
|
$53,928
$24.55 P/Share
|
|
Jan 16
2024
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
1,316
-0.9%
|
$31,584
$24.55 P/Share
|
|
Jan 16
2024
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
2,318
-0.98%
|
$55,632
$24.55 P/Share
|
|
Jan 16
2024
|
Michael J. Davidoff SVP, Payer Business |
SELL
Open market or private sale
|
Direct |
1,310
-1.42%
|
$31,440
$24.55 P/Share
|
|
Jan 16
2024
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
738
-0.56%
|
$17,712
$24.55 P/Share
|
|
Jan 16
2024
|
Balaji Gandhi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
932
-0.87%
|
$22,368
$24.55 P/Share
|
|
Jan 12
2024
|
Janet Gunzburg Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
205
-0.51%
|
$4,920
$24.11 P/Share
|
|
Jan 02
2024
|
Chaim Indig Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,000
+3.17%
|
-
|
|
Jan 02
2024
|
Evan Roberts Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,000
+2.68%
|
-
|
|
Jan 02
2024
|
David Linetsky SVP, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
22,000
+8.49%
|
-
|
|
Jan 02
2024
|
Allison C Hoffman General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
30,500
+17.3%
|
-
|
|
Jan 02
2024
|
Amy Beth Van Duyn SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+8.73%
|
-
|
|
Jan 02
2024
|
Balaji Gandhi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,000
+16.97%
|
-
|